Cambridge Biomedical Campus sign

CBC Limited

Our purpose is to support the sustainable development of the site to keep it globally competitive as a centre for health, education and life sciences

CBC Ltd is neither a landowner nor a developer, although some of our members own land (none of which is subject to proposals for expansion into the Green Belt). However, we do work with local government and landowners to share our views on how the Campus should develop.

We want to make the Campus a better place to work, visit and live beside.

Non-profit Partnership

CBC Ltd was created in 2021 as a non-profit partnership which represents the health, research, education and life science organisations located on the Cambridge Biomedical Campus:

  • Royal Papworth Hospital Black and White
  • MRC Lab of Molecular Biology
  • Cambridgeshire and Peterborough NHS Foundation Trust
The team behind CBC Ltd on the Cambridge Biomedical Campus

Approach

We want to make the Campus a better place to work, visit and live beside

CBC Ltd members have an important contribution to make in shaping plans for how the Campus evolves – we are well placed to articulate how the collaboration between healthcare, education and life science partners can be harnessed to the benefit of local people, in particular through improved healthcare outcomes, scientific discovery and economic development.

We work with local government and landowners to share our views on how the Campus should develop to realise these benefits. This includes promoting a holistic approach to development, understanding the housing requirements of organisations on the Campus and promoting sustainable travel to, from and across the Campus.

We also recognise the wider spectrum of essential public infrastructure which is required for growth to be sustainable and inclusive and we are working with partners across the city to make the case for that infrastructure investment.

We want to give employers, staff and the public the chance to shape the Campus by understanding the views of our community and those most affected by what happens on the site. You can find out more about future plans as well as our Local Voices programme here.

We provide a coherent, compelling and collective narrative to government and key stakeholders, supporting policy and the objectives of members.

We also want to ensure that all stakeholders, including the public, are aware of how they will be engaged on landowner-led submissions to the formal local planning processes, which form an important part of our local democracy.

Kristin-Anne Rutter and Nick Kirby Cambridge Biomedical Campus Limited

Our Executive Leadership

Dr Kristin-Anne Rutter
Executive Director
of Cambridge Biomedical Campus Ltd.

Nick Kirby
Managing Director
of Cambridge Biomedical Campus Ltd.

Directors of CBC

  • Laurel Powers-Freeling, Chair of Cambridge Biomedical Campus Ltd.
  • Dr John Baker, PhD. Senior Vice President, Supply Chain &
    Manufacturing at Abcam.
  • Jan Lowe, Director of the MRC Laboratory of Molecular Biology (LMB)
  • Mike Keech, Chief Finance Officer of Cambridge University Hospitals NHS Foundation Trust (CUH)
  • Eilish Midlane, Chief Executive Officer of Royal Papworth Hospital NHS Foundation Trust
  • Anthony Odgers, Chief Financial Officer University of Cambridge
  • Penny James Chief Operating Officer, BioPharmaceuticals, AstraZeneca
  • Scott Haldane, Interim Chief Executive of Cambridgeshire & Peterborough NHS Foundation Trust
  • We also have a member of our Local Voices Group who acts as a board observer.

Reports

Our publications

Here you can read and download some of the publications created by CBC Limited and its members.

An economic impact assessment of the Cambridge Biomedical Campus. This is a report by the Centre for Economics and Business Research (Cebr), on behalf of the Cambridge Biomedical Campus (CBC), detailing the economic contribution of the CBC to the UK and regional economies. This report predates AstraZeneca’s Discovery Centre opening on the Campus.

Download the CBC Economic Impact Report here.

This report from Carnall Farrar focuses on the impact of healthcare provision and clinical innovation from the Cambridge Biomedical Campus. The report aims to estimate the healthcare impact of the CBC across three domains: NHS activity, clinical innovation, and biomedical research funding.

This report, prepared by Lichfields on behalf of CBC Ltd, presents the findings of a study establishing the housing needs of the workforce at the Cambridge Biomedical Campus.

Download the Housing Report here.

This 2050 Vision was published in 2021 in place of the 2020 Vision, which was published in 2001. It set out our ambitions for Cambridge Biomedical Campus over the following three decades and was informed by an engagement process with local focus groups via Counter Context during the COVID-19 pandemic.

The document is intended as a broad vision for how partners felt the Campus should be developed to support life sciences and healthcare at the time.

Download Vision 2050 here.

Vision 2050 is currently being updated and will be published here soon.

Ensuring staff, patients, business representatives (authorised personnel, contractors etc.) and visitors can travel sustainably to and from the site is an essential part of reducing congestion on Campus, in Cambridge and in the surrounding area.

The CBC Transport Strategy brings the Campus organisations together to collectively deliver improved sustainable travel choices for everybody seeking to access the Campus.

Download the 2018 Transport Strategy here.

CBC Ltd will be publishing a new Transport Strategy in late 2024.

Contact details

Cambridge Biomedical Campus Ltd

Company number:
13471389 – Incorporated on 22 June 2021

Addenbrooke’s Hospital Box 146
Cambridge Biomedical Campus, Hills Road, Cambridge,
United Kingdom, CB2 0QQ

You can find our office on What 3 Words here: https://w3w.co/waters.basis.factor